Medtronic Plc (MDT) Files Form 4 Insider Selling : Richard Kuntz Sells 42,340 Shares

Medtronic Plc (MDT): Richard Kuntz , SrVP & Chief Scien, Clin, Reg of Medtronic Plc sold 42,340 shares on Sep 26, 2016. The Insider selling transaction was reported by the company on Sep 28, 2016 to the Securities and Exchange Commission. The shares were sold at $86.68 per share for a total value of $3,670,053.50 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 19, 2016, Kendall J Powell (director) sold 7,907 shares at $85.44 per share price.On Sep 19, 2016, Omar Ishrak (Chairman & CEO) sold 61,925 shares at $84.93 per share price.Also, On Aug 31, 2016, Bryan C Hanson (EVP, President, MITG) sold 15,000 shares at $87.00 per share price.On Jul 19, 2016, Geoffrey Martha (EVP & GroupPres Restora Therap) sold 3,766 shares at $88.26 per share price.

Medtronic PLC: On Tuesday, Sep 27, 2016 heightened volatility was witnessed in Medtronic PLC which led to swings in the share price. The shares opened for trading at $86.16 and hit $86.78 on the upside , eventually ending the session at $86.67, with a gain of 0.63% or 0.54 points. The heightened volatility saw the trading volume jump to 37,22,731 shares. The 52-week high of the share price is $89.27 and the company has a market cap of $119,772 M . The 52-week low of the share price is at $63.98.

Medtronic PLC Money Flow Index Chart

Company has been under the radar of several Street Analysts.Medtronic PLC is Reiterated by Needham to Buy and the brokerage firm has raised the Price Target to $ 95 from a previous price target of $93 .The Rating was issued on Aug 26, 2016.Medtronic PLC is Initiated by Citigroup to Buy and the brokerage firm has set the Price Target at $102. The Rating was issued on Aug 23, 2016.

Medtronic plc (Medtronic) is a medical technology and services company. The Company develops manufactures and markets its medical devices and technologies to hospitals physicians clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group Minimally Invasive Technologies Group Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine Neuromodulation Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic Inc. is a subsidiary of the Company.

Leave a Reply

Medtronic PLC - Is it time to Sell?

Top Brokerage Firms are advising their investors on Medtronic PLC. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.